Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques
Viruses · 2023
DOI: 10.3390/v15091944 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Siva Thirugnanam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Tulane National Primate Research Center, Covington, LA 70433, USA. Hauptthemen laut MEDLINE: HIV Infections, Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Previous studies have indicated that the loss of CD161-expressing CD4+ Th17 cells is linked to the progression of chronic HIV. These cells are significantly depleted in peripheral blood and gut mucosa of HIV-infected individuals, contributing to inflammation and disruption of the gut barrier. However, the impact of HIV infection on CD161-expressing CD8+ T cells remain unclear. Here, we examined the functions of peripheral blood and mucosal CD161+CD8+ T cells in the macaque model of HIV infection. In contrast to the significant loss of CD161+CD4+ T cells, CD161+CD8+ T cell frequencies were maintained in blood and gut during chronic SIV infection. Furthermore, gut CD161+CD8+ T cells displayed greater IL-17 production and maintained Th1-type and cytolytic functions, contrary to impaired IL-17 and granzyme-B production in CD161+CD4+ T cells of SIV-infected macaques. These results suggest that augmented Th17-type effector functions of CD161+CD8+ T cells during SIV infection is a likely mechanism to compensate for the sustained loss of gut mucosal Th17 cells. Targeting the cytokine and cytolytic effector functions of CD161+CD8+ T cells in the preclinical setting of chronic SIV infection with antiretroviral therapy has implications in the restoration of gut barrier disruption in persons with HIV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tulane National Primate Research Center, Covington, LA 70433, USA.
- Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
- Tulane Center for Aging, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Förderung
- NIH HHS
- NIDDK NIH HHS
- NIMH NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Thirugnanam, S., Walker, E. M., Schiro, F., Aye, P. P., Rappaport, J., & Rout, N. (2023). Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques. Viruses. https://doi.org/10.3390/v15091944
Vancouver
Thirugnanam S, Walker EM, Schiro F, Aye PP, Rappaport J, Rout N. Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques. Viruses. 2023. doi:10.3390/v15091944
BibTeX
@article{Thirugnanam2023,
author = {Thirugnanam, Siva and Walker, Edith M and Schiro, Faith and Aye, Pyone P and Rappaport, Jay and Rout, Namita},
title = {Enhanced IL-17 Producing and Maintained Cytolytic Effector Functions of Gut Mucosal CD161+CD8+ T Cells in SIV-Infected Rhesus Macaques},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15091944}
}
EUVIMED